Symbols / OGEN $0.60 -0.73% Oragenics, Inc.
OGEN Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteOragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Ratings
Current target
$0.60
Low
—
High
—
Mean
—
- ORAGENICS INC (OGEN) Stock Chart - ChartMill Fri, 05 Jun 2026 07
- $OGEN stock is down 9% today. Here's what we see in our data. - Quiver Quantitative hu, 22 Jan 2026 08
- symbol__ Stock Quote Price and Forecast - CNN hu, 08 Feb 2024 18
- Oragenics Inc. (OGEN) stock price prediction 2026–2030 - Bitget Wed, 11 Feb 2026 20
- Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants - Yahoo Finance ue, 01 Jul 2025 07
- Oragenics stock tumbles after announcing $20 million preferred stock offering - Investing.com ue, 01 Jul 2025 07
- Oragenics (OGEN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat Mon, 06 Oct 2025 18
- Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN Wed, 02 Jul 2025 07
- OGEN stock touches 52-week low at $0.24 amid sharp annual decline - Investing.com hu, 27 Mar 2025 07
- OGEN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI Mon, 19 Aug 2024 07
- Biotech CNS raises $22.5M to buy clinical-stage drug assets - Stock Titan Mon, 04 May 2026 07
- Ogen is latest Canadian cannabis producer to close its doors - MJBizDaily ue, 07 Nov 2023 08
- Alteogen merges two subsidiaries, forming Alteogen Biologics - BioWorld News ue, 27 May 2025 07
- These stocks that are showing activity before the opening bell on Monday. - ChartMill Mon, 02 Jun 2025 07
- Elliott Investment Management Sends Letter to the Board of Western Digital Corporation - PR Newswire ue, 03 May 2022 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
9.36
-11.33%
|
10.56
-49.49%
|
20.90
+44.96%
|
14.42
|
| Research And Development |
|
2.39
-41.85%
|
4.11
-73.44%
|
15.49
+53.79%
|
10.07
|
| Selling General And Administration |
|
6.97
+8.15%
|
6.44
+18.20%
|
5.45
+21.71%
|
4.48
|
| General And Administrative Expense |
|
6.97
+8.15%
|
6.44
+18.20%
|
5.45
+21.71%
|
4.48
|
| Other Gand A |
|
6.97
+8.15%
|
6.44
+18.20%
|
5.45
+21.71%
|
4.48
|
| Other Operating Expenses |
|
—
|
—
|
-0.04
+71.37%
|
-0.13
|
| Total Expenses |
|
9.36
-11.33%
|
10.56
-49.49%
|
20.90
+44.96%
|
14.42
|
| Operating Income |
|
-9.36
+11.33%
|
-10.56
+49.49%
|
-20.90
-44.96%
|
-14.42
|
| Total Operating Income As Reported |
|
-9.36
+11.33%
|
-10.56
+49.49%
|
-20.90
-44.96%
|
-14.42
|
| EBITDA |
|
-9.19
+12.76%
|
-10.54
+48.84%
|
-20.60
-44.76%
|
-14.23
|
| Normalized EBITDA |
|
-9.18
+12.68%
|
-10.51
+48.96%
|
-20.60
-44.76%
|
-14.23
|
| Reconciled Depreciation |
|
—
|
0.00
-100.00%
|
0.03
-38.68%
|
0.04
|
| EBIT |
|
-9.19
+12.76%
|
-10.54
+48.91%
|
-20.63
-44.50%
|
-14.27
|
| Total Unusual Items |
|
-0.01
+47.59%
|
-0.03
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-0.01
+47.59%
|
-0.03
|
—
|
—
|
| Net Income |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Pretax Income |
|
-9.98
+5.57%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Non Operating Interest Income Expense |
|
-0.60
-3856.93%
|
0.02
-91.06%
|
0.18
+48.85%
|
0.12
|
| Interest Expense Non Operating |
|
0.79
+2534.87%
|
0.03
-2.49%
|
0.03
+102.55%
|
0.02
|
| Net Interest Income |
|
-0.60
-3856.93%
|
0.02
-91.06%
|
0.18
+48.85%
|
0.12
|
| Interest Expense |
|
0.79
+2534.87%
|
0.03
-2.49%
|
0.03
+102.55%
|
0.02
|
| Interest Income Non Operating |
|
0.18
+297.04%
|
0.05
-78.19%
|
0.21
+54.82%
|
0.14
|
| Interest Income |
|
0.18
+297.04%
|
0.05
-78.19%
|
0.21
+54.82%
|
0.14
|
| Other Income Expense |
|
-0.01
+47.59%
|
-0.03
-136.29%
|
0.07
+498.89%
|
0.01
|
| Other Non Operating Income Expenses |
|
—
|
—
|
0.07
+498.89%
|
0.01
|
| Gain On Sale Of Security |
|
-0.01
+47.59%
|
-0.03
|
—
|
—
|
| Tax Provision |
|
-0.14
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Income From Continuing Operation Net Minority Interest |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Income From Continuing And Discontinued Operation |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Net Income Continuous Operations |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Normalized Income |
|
-9.83
+6.77%
|
-10.54
+48.96%
|
-20.66
-44.56%
|
-14.29
|
| Net Income Common Stockholders |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Diluted EPS |
|
-4.56
+90.48%
|
-47.88
+82.61%
|
-275.40
-29.11%
|
-213.30
|
| Basic EPS |
|
-4.56
+90.48%
|
-47.88
+82.61%
|
-275.40
-29.11%
|
-213.30
|
| Basic Average Shares |
|
2.16
+877.24%
|
0.22
+194.35%
|
0.07
+11.97%
|
0.07
|
| Diluted Average Shares |
|
2.16
+877.24%
|
0.22
+194.35%
|
0.07
+11.97%
|
0.07
|
| Diluted NI Availto Com Stockholders |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Other Taxes |
|
—
|
—
|
—
|
0.01
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
4.97
|
| Current Assets |
|
3.87
|
| Cash Cash Equivalents And Short Term Investments |
|
3.48
|
| Cash And Cash Equivalents |
|
3.48
|
| Other Short Term Investments |
|
—
|
| Receivables |
|
—
|
| Other Receivables |
|
—
|
| Accrued Interest Receivable |
|
—
|
| Prepaid Assets |
|
—
|
| Other Current Assets |
|
0.38
|
| Total Non Current Assets |
|
1.10
|
| Net PPE |
|
0.01
|
| Gross PPE |
|
0.01
|
| Accumulated Depreciation |
|
0.00
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.00
|
| Other Properties |
|
0.01
|
| Leases |
|
0.00
|
| Non Current Prepaid Assets |
|
1.09
|
| Total Liabilities Net Minority Interest |
|
1.80
|
| Current Liabilities |
|
1.80
|
| Payables And Accrued Expenses |
|
1.47
|
| Payables |
|
1.24
|
| Accounts Payable |
|
1.24
|
| Current Accrued Expenses |
|
0.22
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.01
|
| Current Debt And Capital Lease Obligation |
|
0.32
|
| Current Debt |
|
0.31
|
| Current Capital Lease Obligation |
|
0.01
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.00
|
| Stockholders Equity |
|
3.17
|
| Common Stock Equity |
|
1.58
|
| Capital Stock |
|
1.60
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
1.59
|
| Share Issued |
|
0.10
|
| Ordinary Shares Number |
|
0.10
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
207.79
|
| Retained Earnings |
|
-206.22
|
| Total Equity Gross Minority Interest |
|
3.17
|
| Total Capitalization |
|
3.17
|
| Working Capital |
|
2.07
|
| Invested Capital |
|
1.89
|
| Total Debt |
|
0.32
|
| Capital Lease Obligations |
|
0.01
|
| Net Tangible Assets |
|
3.17
|
| Tangible Book Value |
|
1.58
|
| Current Notes Payable |
|
0.31
|
| Preferred Stock Equity |
|
1.59
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-9.25
-7.55%
|
-8.60
-17.92%
|
-7.29
+52.12%
|
-15.23
|
| Cash Flow From Continuing Operating Activities |
|
-9.25
-7.55%
|
-8.60
-17.92%
|
-7.29
+52.12%
|
-15.23
|
| Net Income From Continuing Operations |
|
-9.84
+6.86%
|
-10.57
+48.84%
|
-20.66
-44.56%
|
-14.29
|
| Depreciation Amortization Depletion |
|
—
|
0.00
-100.00%
|
0.03
-38.68%
|
0.04
|
| Depreciation And Amortization |
|
—
|
0.00
-100.00%
|
0.03
-38.68%
|
0.04
|
| Other Non Cash Items |
|
0.90
|
—
|
10.27
|
—
|
| Stock Based Compensation |
|
0.56
+7.69%
|
0.52
-49.25%
|
1.02
+37.00%
|
0.74
|
| Operating Gains Losses |
|
—
|
—
|
0.03
+373.22%
|
-0.01
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.03
+373.22%
|
-0.01
|
| Change In Working Capital |
|
-0.86
-158.94%
|
1.45
-27.89%
|
2.02
+217.55%
|
-1.72
|
| Change In Receivables |
|
-0.05
|
0.00
|
0.00
-100.00%
|
0.01
|
| Change In Prepaid Assets |
|
-1.01
-163.98%
|
1.57
-21.32%
|
2.00
+205.33%
|
-1.90
|
| Change In Payables And Accrued Expense |
|
0.20
+269.57%
|
-0.12
-564.38%
|
0.03
-85.39%
|
0.18
|
| Change In Other Current Assets |
|
0.00
-100.00%
|
0.01
-97.09%
|
0.34
|
0.00
|
| Change In Other Current Liabilities |
|
0.00
+100.00%
|
-0.01
+97.17%
|
-0.35
|
—
|
| Investing Cash Flow |
|
—
|
0.00
+100.00%
|
-0.94
-710.50%
|
-0.12
|
| Cash Flow From Continuing Investing Activities |
|
—
|
0.00
+100.00%
|
-0.94
-710.50%
|
-0.12
|
| Net PPE Purchase And Sale |
|
—
|
0.00
-100.00%
|
0.06
+155.16%
|
-0.12
|
| Purchase Of PPE |
|
—
|
—
|
0.00
+100.00%
|
-0.13
|
| Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.06
+430.97%
|
0.01
|
| Capital Expenditure |
|
—
|
—
|
-1.00
-684.20%
|
-0.13
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-1.00
|
0.00
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-1.00
|
0.00
|
| Financing Cash Flow |
|
16.78
+180.68%
|
5.98
+2006.07%
|
0.28
+157.36%
|
-0.49
|
| Cash Flow From Continuing Financing Activities |
|
16.78
+180.68%
|
5.98
+2006.07%
|
0.28
+157.36%
|
-0.49
|
| Net Issuance Payments Of Debt |
|
-0.87
-25.90%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Issuance Of Debt |
|
2.46
|
0.00
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-3.33
-380.23%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Short Term Debt Issuance |
|
2.46
|
0.00
|
0.00
|
0.00
|
| Short Term Debt Payments |
|
-3.33
-380.23%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Net Short Term Debt Issuance |
|
-0.87
-25.90%
|
-0.69
-22.45%
|
-0.57
-0.33%
|
-0.56
|
| Net Common Stock Issuance |
|
2.63
-60.52%
|
6.67
+684.99%
|
0.85
+1126.64%
|
0.07
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Changes In Cash |
|
7.53
+387.74%
|
-2.62
+67.03%
|
-7.94
+49.85%
|
-15.84
|
| Beginning Cash Position |
|
0.86
-75.17%
|
3.48
-69.51%
|
11.43
-58.09%
|
27.27
|
| End Cash Position |
|
8.40
+871.25%
|
0.86
-75.17%
|
3.48
-69.51%
|
11.43
|
| Free Cash Flow |
|
-9.25
-7.55%
|
-8.60
-3.70%
|
-8.29
+46.01%
|
-15.36
|
| Interest Paid Supplemental Data |
|
0.02
-25.06%
|
0.03
-2.49%
|
0.03
+229.29%
|
0.01
|
| Common Stock Issuance |
|
2.63
-60.52%
|
6.67
+684.99%
|
0.85
+1126.64%
|
0.07
|
| Issuance Of Capital Stock |
|
17.65
+164.60%
|
6.67
+684.99%
|
0.85
+1126.64%
|
0.07
|
| Net Preferred Stock Issuance |
|
15.02
|
0.00
|
—
|
0.00
|
| Preferred Stock Issuance |
|
15.02
|
0.00
|
—
|
—
|
| Preferred Stock Payments |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-05-19 View
- 10-Q2026-05-08 View
- 8-K2026-05-07 View
- 8-K2026-04-13 View
- 8-K2026-03-31 View
- 10-K2026-03-16 View
- 8-K2026-03-11 View
- 8-K2026-01-22 View
- 8-K2026-01-20 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-12-15 View
- 8-K2025-12-15 View
- 8-K2025-11-12 View
- 10-Q2025-11-07 View
- 8-K2025-10-21 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|